Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Calidi Biotherapeutics, Inc. Common Stock (NY: CLDI )

1.360 +0.010 (+0.74%)
Official Closing Price Updated: 8:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Calidi Biotherapeutics, Inc. Common Stock

< Previous 1 2 3 4 Next >
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Join Calidi Biotherapeutics’ Exclusive Live Investor Webinar and Q&A Session on April 24
From Calidi Biotherapeutics, Inc.
Via Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Calidi Biotherapeutics, Inc. Announces Closing of $6.1 Million Public Offering
From Calidi Biotherapeutics, Inc.
Via Business Wire
S&P 500 Edges Lower; PacBio Shares Plunge
U.S. stocks traded mixed toward the end of trading, with the S&P 500 falling around 0.3% on Tuesday. The Dow traded up 0.02% to 37,741.96 while the NASDAQ fell 0.20% to 15,853.39. The S&P 500 also... 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Skillsoft Corp. (NASDAQ: SKIL) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter financial results and issued FY25 revenue guidance below estimates. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Gold Moves Higher; Morgan Stanley Earnings Top Views
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite falling around 0.2% on Tuesday. The Dow traded up 0.13% to 37,784.21 while the NASDAQ fell 0.20% to 15,853.34. The S&P 500... 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Calidi Biotherapeutics (CLDI) Shares Are Down Over 50%
Calidi Biotherapeutics shares are trading lower by 54% during Tuesday's session. The company announced the pricing of a $6.1 million public offering. 
Via Benzinga
BZFD Stock: BuzzFeed Is Prepping for a Reverse Stock Split
BuzzFeed stock is falling on Tuesday after the media company announced plans for a reverse stock split to boost the price of BZFD shares. 
Via InvestorPlace
Dow Gains Over 100 Points; Bank of America Posts Upbeat Profit
U.S. stocks traded mixed this morning, with the Dow Jones index gaining more than 100 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.35% to 37,865.71 while the NASDAQ fell... 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Is Calidi Biotherapeutics (CLDI) Stock Down 51% Today?
Calidi Biotherapeutics stock is falling hard on Tuesday after the company priced a public offering for more than 15 million shares of CLDI. 
Via InvestorPlace
Calidi Biotherapeutics, Inc. Announces Pricing of $6.1 Million Public Offering
From Calidi Biotherapeutics, Inc.
Via Business Wire
Why Macatawa Bank Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket
Shares of Macatawa Bank Corporation (NASDAQ: MCBC) rose sharply in today’s pre-market trading after Wintrust Financial Corporation (NASDAQ: WFTC) and Macatawa Bank announced that they have entered into... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Pre-market stock movers are worth diving into on Tuesday as we check out all of the biggest changes and the news behind them! 
Via InvestorPlace
Calidi Biotherapeutics Presents New Data on the Mechanisms of Action for Virotherapy-Loaded Stem Cells Used in the Company’s Novel Immunotherapies at the AACR Annual Meeting 2024
From Calidi Biotherapeutics, Inc.
Via Business Wire
CLDI Stock Earnings: Calidi Biotherapeutics Misses EPS for Q4 2023
CLDI stock results show that Calidi Biotherapeutics missed analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
Calidi Biotherapeutics Reports Fourth Quarter and Full-Year 2023 Operating and Financial Results
From Calidi Biotherapeutics, Inc.
Via Business Wire
Calidi Biotherapeutics and City of Hope Announce Funding from the California Institute for Regenerative Medicine (CIRM) to Advance CLD-101 (NeuroNova) in Ovarian Cancer
From Calidi Biotherapeutics, Inc.
Via Business Wire
Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Helix Energy Solutions Group, Inc. (NYSE: HLX) fell sharply during Tuesday’s session following weak earnings. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Calidi Biotherapeutics to Highlight Novel Systemic Enveloped Oncolytic Virotherapy Platform Designed to Target All Tumor Sites at Upcoming Conference
From Calidi Biotherapeutics, Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why CommScope Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of CommScope Holding Company, Inc. (NASDAQ: COMM) fell sharply during Monday’s session. B of A Securities analyst Tal Liani downgraded CommScope from Neutral to Underperform and lowered the... 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.